Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Folinsbee Thomas — Summit Healthcare Acquisition Corp. insider: 1 transactions · InsiderLens

Home / Insiders / Folinsbee Thomas

Folinsbee Thomas

Director at CASI Pharmaceuticals, Inc. · on record since Apr 23, 2026
Director at Summit Healthcare Acquisition Corp. · on record since Jun 8, 2021
Director at Bison Capital Acquisition Corp. · on record since Jun 20, 2017

Insider trading activity of Folinsbee Thomas

Transactions on record: 1; since Mar 21, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 21, 2023

Figures computed from official regulatory filings — methodology.

Companies where Folinsbee Thomas has traded

Summit Healthcare Acquisition Corp.1 tx · Mar 21, 2023

Track record of Folinsbee Thomas

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Folinsbee Thomas

Co-insiders of Folinsbee Thomas

Bai TaoSummit Healthcare Acquisition Corp.
Bison Capital Holding Co LtdBison Capital Acquisition Corp.
Brookline Capital Holdings LLCBison Capital Acquisition Corp.
Buchanan William B. Jr.Bison Capital Acquisition Corp.
Bu FanBison Capital Acquisition Corp.
Chhabra MeenuBison Capital Acquisition Corp.
CROSS HERBBison Capital Acquisition Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Duke William E.Bison Capital Acquisition Corp.

Dupont JakobBison Capital Acquisition Corp.

Gao Wei RCASI Pharmaceuticals, Inc.

GLAZER CAPITAL, LLCBison Capital Acquisition Corp.

GLAZER PAUL JBison Capital Acquisition Corp.

Hauslein James NBison Capital Acquisition Corp.

He Wei-WuCASI Pharmaceuticals, Inc.

Hsu Frank J.Bison Capital Acquisition Corp.

Huang HaiCASI Pharmaceuticals, Inc.

Jiang FengyunBison Capital Acquisition Corp.

Jin PengBison Capital Acquisition Corp.

Katzmann Scott ABison Capital Acquisition Corp.

Kou Jinwei CocoBison Capital Acquisition Corp.

Krebs-Pohl Barbara Helene HanneloreCASI Pharmaceuticals, Inc.

PEERSCHKE ELGARBison Capital Acquisition Corp.

Poon Cho FaiSummit Healthcare Acquisition Corp.

Prizzi Charles VincentBison Capital Acquisition Corp.

Qian KunCASI Pharmaceuticals, Inc.

Qian TingzhiBison Capital Acquisition Corp.

RINGOLD GORDONBison Capital Acquisition Corp.

Sarena Francis WillardBison Capital Acquisition Corp.

SERAFINI TITOBison Capital Acquisition Corp.

Smith Scott AndrewBison Capital Acquisition Corp.

Stone Ian CharlesSummit Healthcare Acquisition Corp.

Sturgeon Patrick ABison Capital Acquisition Corp.

Summit Healthcare Acquisition Sponsor LLCSummit Healthcare Acquisition Corp.

Tan BoSummit Healthcare Acquisition Corp.

TONG JAMES JIAYUANBison Capital Acquisition Corp.

Wang ChunhuaCASI Pharmaceuticals, Inc.

Wang NingBison Capital Acquisition Corp.

Wertheimer Samuel PBison Capital Acquisition Corp.

Wong AmyBison Capital Acquisition Corp.

Wu AlexCASI Pharmaceuticals, Inc.

Wu PeidongBison Capital Acquisition Corp.

Wu Wentao JasonBison Capital Acquisition Corp.

Xu PeixinBison Capital Acquisition Corp.

Xu Yinglin MarkBison Capital Acquisition Corp.

Yang XiaodongBison Capital Acquisition Corp.

Zabrowski DanBison Capital Acquisition Corp.

Zeng XueboCASI Pharmaceuticals, Inc.

Zukiwski Alexander ACASI Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Summit Healthcare Acquisition Corp.	Mar 21, 2023	OtherD	-25,000	—	—	SEC